ResearcherHarbin Medical UniversityActive in the last 2 years
Dongbo Xue
Matched on ORCID iD 0000-0001-9012-4805; OpenAlex author ID A5000598821. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 3 papers · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 8
- TCN1 Drives Malignant Progression of Pancreatic Cancer Through STAT4-Mediated Transcriptional Activation of the DUOX2/ROS Signaling Axis. Co-author DOI 10.3390/cancers17203300↗
- The Significance of Monocyte Infiltration in the Immune Microenvironment for the Prognosis and Treatment of Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-2845424/v1↗
- Integration of scRNA-seq and Bulk-seq to Analyse the Infiltration of Monocytes in Pancreatic Cancer and Establish a Molecular Risk Model Co-author DOI 10.21203/rs.3.rs-2397635/v1↗
- Identification of hub genes in chronic pancreatitis and analysis of association with pancreatic cancer via bioinformatic analysis. Last author DOI 10.4149/gpb_2021033↗
- Dictamnine inhibits pancreatic cancer cell growth and epithelial-mesenchymal transition by blocking the PI3K/AKT signaling pathway. Co-author DOI 10.4149/neo_2022_211016n1474↗
- Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network. Co-author DOI 10.18632/oncotarget.11517↗
- Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway. Co-author DOI 10.1007/s00280-011-1643-7↗
- Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions. Co-author DOI 10.1371/journal.pone.0023752↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yongwei Wang · 3 shared papers, 2011–2025 · strength 0.39
- Paper TCN1 Drives Malignant Progression of Pancreatic Cancer Through STAT4-Mediated Transcriptional Activation of the DUOX2/R… DOI 10.3390/cancers17203300↗
- Paper Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network. DOI 10.18632/oncotarget.11517↗
- Paper Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cell… DOI 10.1371/journal.pone.0023752↗
- Yingmei Zhang · 3 shared papers, 2011–2023 · strength 0.33
- Paper The Significance of Monocyte Infiltration in the Immune Microenvironment for the Prognosis and Treatment of Pancreatic … DOI 10.21203/rs.3.rs-2845424/v1↗
- Paper Integration of scRNA-seq and Bulk-seq to Analyse the Infiltration of Monocytes in Pancreatic Cancer and Establish a Mol… DOI 10.21203/rs.3.rs-2397635/v1↗
- Paper Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cell… DOI 10.1371/journal.pone.0023752↗
- Wenchao Yao · 2 shared papers, 2022–2023 · strength 0.31
- Paper The Significance of Monocyte Infiltration in the Immune Microenvironment for the Prognosis and Treatment of Pancreatic … DOI 10.21203/rs.3.rs-2845424/v1↗
- Paper Integration of scRNA-seq and Bulk-seq to Analyse the Infiltration of Monocytes in Pancreatic Cancer and Establish a Mol… DOI 10.21203/rs.3.rs-2397635/v1↗
- Zonglin Liu · 1 shared paper, 2025 · strength 0.30
- Hongxuan Li · 1 shared paper, 2022 · strength 0.19
- Ye Song · 1 shared paper, 2022 · strength 0.16
- Weihui Zhang · 1 shared paper, 2022 · strength 0.16
- Zhiqiang Zhang · 1 shared paper, 2022 · strength 0.16
- Qiang Wang · 1 shared paper, 2022 · strength 0.14
- Bei Sun · 3 shared papers, 2011–2016 · strength 0.11
- Paper Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network. DOI 10.18632/oncotarget.11517↗
- Paper Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway. DOI 10.1007/s00280-011-1643-7↗
- Paper Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cell… DOI 10.1371/journal.pone.0023752↗
- Shangha Pan · 3 shared papers, 2011–2016 · strength 0.11
- Paper Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network. DOI 10.18632/oncotarget.11517↗
- Paper Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway. DOI 10.1007/s00280-011-1643-7↗
- Paper Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cell… DOI 10.1371/journal.pone.0023752↗
- Rui Kong · 3 shared papers, 2011–2016 · strength 0.11
- Paper Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network. DOI 10.18632/oncotarget.11517↗
- Paper Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway. DOI 10.1007/s00280-011-1643-7↗
- Paper Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cell… DOI 10.1371/journal.pone.0023752↗
- Yilong Li · 1 shared paper, 2016 · strength 0.07
- Xuewei Bai · 2 shared papers, 2011 · strength 0.05
- Hongchi Jiang · 2 shared papers, 2011 · strength 0.05
- Zhuoxin Cheng · 2 shared papers, 2011 · strength 0.05
- Shuangjia Wang · 2 shared papers, 2011 · strength 0.05
- Hua Chen · 1 shared paper, 2011 · strength 0.02
- Guang Jia · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.